Lens Diseases: Clinical Trials

96 trials for Lens Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

71 completed, 9 unknown, 7 terminated, 6 recruiting. 96 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 396Completed 71, Unknown 9, Terminated 7, Recruiting 6, Withdrawn 3
Phase 26Unknown 3, Completed 2, Terminated 1

Follow Lens Diseases: new trials by email Literature Review of Lens Diseases trials Research Report on Lens Diseases

Trials (filtered) newest first · largest first

All 96 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
Bimatoprost Implant System, SpyGlass IOL, Timolol Maleate Ophthalmic Solution, 0.5% - Cataract, Glaucoma
Phase 3RecruitingSpyGlass Pharma, Inc.4002025-10-282025-10-20
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
Bimatoprost Implant System, SpyGlass IOL, Timolol Maleate Ophthalmic Solution, 0.5% - Cataract, Glaucoma
Phase 3RecruitingSpyGlass Pharma, Inc.4002025-10-152025-10-20
Intranasal Dexmedetomidine on Blood Pressure in Elderly Hypertensive Patients Undergoing Cataract Surgery
Intranasal dexmedetomidine, Intranasal normal saline - Cataract, Hypertension
Phase 3RecruitingSuez Canal University1262025-07-162026-04-07
Treatment of Retinal Detachment in People Who Have Not Had Cataract Surgery With Vitrectomy vs Vitrectomy and Cataract Removal
Phacovitrectomy, Vitrectomy - Rhegmatogenous Retinal Detachment
Phase 3RecruitingQueen's University, Belfast2762025-05-162026-10-27
The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery
Ripasudil, Placebo - Fuchs' Endothelial Dystrophy, Cataract
Phase 3RecruitingSingapore Eye Research Institute1202025-03-012025-01-29
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet - Cataract
Phase 3UnknownMelt Pharmaceuticals5282024-05-012024-08-02
A Study to Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Cataract Surgery (2)
Dexycu, Placebo/Vehicle - Cataract
Phase 3WithdrawnEyePoint Pharmaceuticals, Inc.2022-09-012024-04-03
A Study to Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Cataract Surgery
Dexycu, Placebo/Vehicle - Cataract
Phase 3WithdrawnEyePoint Pharmaceuticals, Inc.2022-09-012025-08-11
Study of Dexycu in Treating Intraocular Inflammation
Dexycu, Placebo - Inflammation, Cataract
Phase 3CompletedOcumension Therapeutics (Shanghai) Co., Ltd2852022-08-222024-08-26
Effectiveness of Periocular Drug Injection in CATaract Surgery
Bromfenac, Dexamethasone, Triamcinolone Acetonide - Macular Edema, Cystoid Macular Edema
Phase 3TerminatedLuigi Rondas6282021-10-132024-11-04
Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery
The study will include three arms, one non interventional and 2 interventions. The intervention arms will include two commercially available sodium hyaluronate 0.1% (Systane ultra plus and Hylo-comod) - Dry Eye Disease, Dry Eye Syndrome
Phase 3UnknownFundación Oftalmológica Los Andes1002021-01-152021-01-15
Hypochlorous Acid Disinfection Prior to Cataract Surgery
Hypochlorous Acid Gel 0.02% - Cataract, Endophthalmitis
Phase 3CompletedLoma Linda University542020-10-292023-02-21
Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes.
Triamcinolone Acetonide - Diabete Type 2, Cataract
Phase 2 / Phase 3CompletedDamascus University732020-09-122023-04-26
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
Chloroprocaine 3%, Tetracaine 0.5% - Cataract
Phase 3CompletedSintetica SA3382020-09-092023-01-18
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
Dextenza Ophthalmic Insert, Prednisolone acetate ophthalmic suspension USP 1% - Cataract
Phase 3CompletedOcular Therapeutix, Inc.652020-09-042024-04-15
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)
Clobetasol propionate, Vehicle - Cataract
Phase 3CompletedSalvat2502020-06-102022-12-22
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)
Clobetasol Propionate, Vehicle - Cataract
Phase 3CompletedSalvat2152020-06-042022-12-22
Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery
Lucentis - Diabetic Macular Edema, Cataract
Phase 3UnknownSecond Military Medical University902019-08-222020-03-26
Evaluation of Treatment Option for Demodicosis in Patients Undergoing Cataract Surgery
Tea Tree Oil Shampoo, Ciprofloxacin Ophthalmic Ointment 0.3%, Baby shampoo - Demodex Infestation, Demodicosis
Phase 2 / Phase 3CompletedHospital de La Luz1602019-05-062020-04-27
Pilocarpine Use After Kahook Goniotomy
Pilocarpine, Prednisolone, Ofloxacin - Glaucoma
Phase 3RecruitingMontefiore Medical Center1422019-05-012025-11-10

Showing 20 of 96. Sign in to see all of them.

Narrower conditions

Cataract (95)  ·  Inflammation (17)  ·  Pain (12)  ·  Glaucoma (7)  ·  Macular Degeneration (4)  ·  Macular Edema (4)  ·  Diabetes Mellitus, Type 2 (3)  ·  Glaucoma, Open-Angle (3)  ·  Corneal Endothelial Cell Loss (2)  ·  Diabetes Mellitus (2)  ·  Diabetes Mellitus, Type 1 (2)  ·  Dry Eye Syndromes (2)  ·  Neoplasms (2)  ·  Ocular Hypertension (2)  ·  Aphakia (1)

Broader conditions

Eye Diseases (95)  ·  Pathological Conditions, Signs and Symptoms (21)  ·  Pathologic Processes (20)  ·  Signs and Symptoms (14)  ·  Neurologic Manifestations (12)  ·  Retinal Degeneration (8)  ·  Retinal Diseases (8)  ·  Ocular Hypertension (6)  ·  Metabolic Diseases (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Endocrine System Diseases (4)  ·  Glucose Metabolism Disorders (4)  ·  Macular Degeneration (4)  ·  Cardiovascular Diseases (3)

Interventions

Calcium Dobesilate (6)  ·  Cataract Extraction (5)  ·  nepafenac (5)  ·  prednisolone acetate (5)  ·  Dexamethasone (4)  ·  Loteprednol Etabonate (4)  ·  R-1,1,1-trifluoro-4-(5-fluoro-2,3-dihydrobenzofuran-7-yl)-4-methyl-2-(((2-methyl-5-quinolyl)amino)methyl)pentan-2-ol (4)  ·  bromfenac (4)  ·  Methylprednisolone (3)  ·  Phacoemulsification (3)  ·  Triamcinolone Acetonide (3)  ·  Aspirin (2)  ·  BID protein, human (2)  ·  Clobetasol (2)  ·  D-JNKI-1 (2)

Sponsors

Alcon Research (14)  ·  Bausch & Lomb Incorporated (14)  ·  Abbott Medical Optics (5)  ·  National Eye Institute (NEI) (5)  ·  Glaukos Corporation (3)  ·  Omeros Corporation (3)  ·  EyePoint Pharmaceuticals, Inc. (2)  ·  ICON Bioscience Inc (2)  ·  Kala Pharmaceuticals, Inc. (2)  ·  LensAR Incorporated (2)  ·  Salvat (2)  ·  SpyGlass Pharma, Inc. (2)  ·  Xigen SA (2)  ·  Actavis Inc. (1)  ·  Amgen (1)

Countries

United States (51)  ·  Mexico (5)  ·  France (4)  ·  Germany (4)  ·  India (4)  ·  Italy (4)  ·  China (3)  ·  Netherlands (3)  ·  Austria (2)  ·  Brazil (2)  ·  Canada (2)  ·  Egypt (2)  ·  Hungary (2)  ·  Portugal (2)  ·  Singapore (2)

Top investigators

Steve Whitaker, MD (3)  ·  Andrew Schwartz, MD (2)  ·  Jeff Wells, PharmD, MBA (2)  ·  Paul Yoo, OD (2)  ·  Rabia Ozden, MD (2)  ·  Stephen Lane (2)  ·  Tim McNamara, PharmD (2)  ·  Abhay R Vasavada, MS, FRCS (1)  ·  Aldo Caporossi, MD, Prof. (1)  ·  Andrew Maxwell (1)  ·  Aung Tin, PhD MD (1)  ·  Blake Harris (1)  ·  Bradley Williams, MD (1)

Results publications

PMID 12424394, PMID 14977340, PMID 24935281, PMID 27810317, PMID 28670710, PMID 42192627, PMID 10801969, PMID 11097601, PMID 11470690, PMID 11594942, PMID 11594943, PMID 11925463, PMID 15136320, PMID 15534261, PMID 15808240, PMID 16019690, PMID 16606880, PMID 16877067, PMID 17502507, PMID 17559787, PMID 17846363, PMID 18201681, PMID 18387406, PMID 18421079, PMID 18779490, PMID 19237716, PMID 19508997, PMID 19636163, PMID 19668532, PMID 20828829, PMID 21397456, PMID 21751945, PMID 22317913, PMID 22814041, PMID 22879423, PMID 23620429, PMID 23644932, PMID 23645227, PMID 23830564, PMID 23887802, PMID 24310343, PMID 24638908, PMID 24974812, PMID 25085962, PMID 25232809, PMID 26305649, PMID 26531052, PMID 27519183, PMID 27526051, PMID 29661413

NIH funding

2005 (1), 2009 (1), 2016 (1), 2019 (1), R01EY014418 (1), U10CA037429 (1)